Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial)-Reference-Cited by-同舟云学术

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial)

Published:2016-04-10 Issue:8 Volume:71 Page:2252-2261
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Slama Laurence,Landman Roland,Assoumou Lambert,Benalycherif Aida,Samri Assia,Joly Véronique,Pialoux Gilles,Valin Nadia,Cabié André,Duvivier Claudine,Lambert-Niclot Sidonie,Marcelin Anne-Geneviève,Peytavin Gilles,Costagliola Dominique,Girard Pierre-Marie

Funder

Bristol-Myers Squibb

IMEA foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/8/2252/16863854/dkw103.pdf

Reference28 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . Department of Health and Human Services. https://aidsinfo.nih.gov/guidelines .

2. EACS Guidelines. 2014. http://eacsociety.org/guidelines .

3. Increases in duration of first highly active antiretroviral therapy over time (1996–2009) and associated factors in the Multicenter AIDS Cohort Study;Slama;J Acquir Immune Defic Syndr,2014

4. Impact of Late Presentation on the Risk of Death Among HIV-Infected People in France (2003–2009)

5. Late presentation of HIV infection: a consensus definition

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients;Viruses;2023-05-08

2. Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors;HIV Medicine;2020-10-13

3. Do interventions to improve adherence to antiretroviral therapy recognise diversity? A systematic review;AIDS Care;2020-08-27

4. A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study);PLOS ONE;2019-09-27

5. Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis;BMC Infectious Diseases;2019-05-30